ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Group chairmen Advises 7 Trials For Priority Status

June 14, 1991

ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7

May 27, 2011

Statement Defining Cancer Control Goals, Approaches Okayed By Board

February 6, 1981

Cancer Vaccine RFAs Approved In Concept By NCI Advisors

July 26, 1991

Adding Ultrasound Revealed More Breast Cancers In Study

May 30, 2008

In Brief: Upton Says Delaney Clause Is Needed: CPSC Drops Effort To Set Policy On Carcinogens

May 4, 1979